Date: October 03, 2026
Preferential Issue Details
Standard Engineering Technology Limited has received in-principle approval from both BSE Limited and National Stock Exchange of India Limited for a preferential issue of equity shares.
- Approval References: BSE Letter No. LOD/PREF/DA/FIP/877/2026-27 dated October 01, 2026; NSE Letter No. NSE/LIST/56391 dated October 01, 2026
- Total Shares: 24,39,750 (Twenty-Four Lakh Thirty-Nine Thousand Seven Hundred and Fifty) fully paid-up Equity Shares
- Face Value: ₹10 per share
- Issue Price: ₹293 per Equity Share (including a premium of ₹283 per share)
- Total Fundraise: Approximately ₹71.5 crore (24,39,750 shares × ₹293)
- Mode of Issue: Preferential basis for cash consideration
Allottee Details
The shares are to be allotted to non-promoter category entities:
| S. No. | Name of Proposed Allottee | Number of Equity Shares |
| 1. | AGI Group Holdings Inc. | 22,77,100 |
| 2. | Monoflus Pte. Ltd. | 1,62,650 |
| | Total | 24,39,750 |
Conditions and Compliance Requirements
Both exchanges have stipulated specific conditions for the preferential issue:
- The company must obtain statutory approvals from SEBI, RBI, MCA and other authorities
- Strict compliance with Chapter V of SEBI (ICDR) Regulations, 2018 and SEBI (LODR) Regulations, 2015
- The company must strengthen internal controls to monitor trades by proposed allottees
- Must obtain undertaking from allottees confirming they will not engage in intra-day trading or any sale in the company scrip until allotment date
- Primary responsibility for verification and compliance rests with the issuer company (Regulation 167(6) of SEBI ICDR regulations, 2018)
- Any non-compliance observed post-undertaking may impact listing of shares
- Listing application must be made within 20 days from date of allotment as per SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023
Next Steps
The company will proceed with allotment upon receipt of requisite consideration from the proposed allottees. The exchanges reserve the right to withdraw this in-principle approval if submitted information is found incomplete, incorrect, misleading, false, or in contravention of any rules and regulations.